Red Wine Compound Resveratrol Emerges as a Potential Booster of Brain Plasticity

A polyphenol that has fascinated researchers for decades is now being cast in a new role: as a molecular tune-up for the connections between brain cells. In a mini review published in Molecular Biology Reports, Amir Hossein Zarifkar of Larestan University of Medical Sciences and Sepideh Safaei of Gerash University of Medical Sciences synthesize evidence that resveratrol, the stilbenoid polyphenol best known from grapes and red wine, can modulate synaptic plasticity, the capacity of neuronal connections to strengthen or weaken in response to activity over time. The review, which received no external funding and declares no competing interests, argues that this modulation could help counteract the cognitive decline that accompanies oxidative stress, aging, and neurodegenerative disease, while also flagging the caveats that still stand between laboratory promise and clinical reality.

Synaptic plasticity is the biological substrate of learning and memory. At its core lies long-term potentiation, or LTP, a persistent strengthening of synaptic transmission that is widely studied in the hippocampus, the seahorse-shaped structure critical for forming new memories. The review situates resveratrol within the established molecular machinery of LTP: the activation of N-methyl-D-aspartate receptors, calcium influx, the recruitment of calcium/calmodulin-dependent protein kinase II, and the insertion and upregulation of AMPA receptors at the postsynaptic membrane. It also points to the signaling cascades that stabilize potentiated synapses, including the phosphoinositide 3-kinase/Akt pathway, the mammalian target of rapamycin, and the cyclic AMP response element binding protein, CREB, which drives the expression of plasticity-related genes. Disruption of any of these nodes, the authors note, can erode the synapse’s ability to encode experience.

One of the most consequential threats to that machinery is oxidative stress. The brain is exceptionally vulnerable to it: it consumes a disproportionate share of the body’s oxygen, is rich in lipids susceptible to peroxidation, and hosts neurons that are selectively sensitive to redox imbalance. When the production of reactive oxygen species outpaces the systems that eliminate them, the resulting damage can impair synaptic proteins, distort receptor signaling, and ultimately push neurons toward apoptosis, a programmed form of cell death that the body uses to maintain cellular equilibrium. The review emphasizes that reactive oxygen species are not simply toxic byproducts; at physiological levels they participate in the regulation of synaptic plasticity and memory, which means the therapeutic goal is restoration of balance rather than wholesale suppression of redox signaling.

Resveratrol enters this picture as a bidirectional modulator. According to the review, the compound can scavenge reactive oxygen species and blunt the damage inflicted by oxidative stress, thereby protecting the molecular substrates of plasticity. It also engages cellular defense systems more broadly, including the Nrf2 signaling pathway, which coordinates the transcription of antioxidant genes. In experimental models, resveratrol treatment has been shown to attenuate neuronal apoptosis after oxygen and glucose deprivation and reoxygenation by enhancing Nrf2 activation, and to protect embryonic neural stem cells from hydrogen peroxide-induced oxidative stress. These findings position the molecule as both a direct antioxidant and an indirect activator of the cell’s own protective programs.

The review gives particular attention to sirtuin 1, or SIRT1, a NAD-dependent deacetylase that resveratrol is known to activate and that has been implicated in synaptic health. In a model of developmental lead exposure, resveratrol reversed injury to hippocampal synaptic markers and countered SIRT1 inhibition, suggesting that the polyphenol can restore a key longevity-linked signaling axis in the brain. In neonatal mice with hypoxic-ischemic brain injury, resveratrol improved synaptic plasticity by alleviating neuroinflammation mediated through the SIRT1/NF-kappaB pathway. The authors also describe work showing that resveratrol upregulates AMPA receptor expression via AMP-activated protein kinase-mediated protein translation, a mechanism that directly increases the availability of the receptors responsible for fast excitatory transmission.

Beyond receptor-level effects, the review highlights resveratrol’s influence on brain-derived neurotrophic factor, BDNF, a growth factor central to the survival and maturation of dendritic spines, the tiny protrusions where excitatory synapses reside. It also examines adult hippocampal neurogenesis, the ongoing generation of new neurons in the dentate gyrus that evidence now supports in humans and that is increasingly recognized as a contributor to learning, memory, and mood regulation. Nutrition is one of the environmental factors known to shape this process, and the review frames resveratrol as a potential hippocampal plasticity enhancer capable of supporting both the birth of new neurons and the functional integration of existing circuits.

The translational implications extend across a striking range of disease models. In rats subjected to chronic cerebral hypoperfusion, resveratrol reversed deficits in synaptic plasticity and prevented cognitive impairment. In an Alzheimer’s-relevant model, it ameliorated spatial learning and memory impairment induced by amyloid-beta(1-42). In streptozotocin-induced diabetic rats, it improved cognitive performance by regulating both apoptosis and synaptic plasticity. The review further cites work showing that resveratrol modulates cocaine-induced inhibitory synaptic plasticity in dopamine neurons of the ventral tegmental area by inhibiting phosphodiesterases, and reports of antidepressant effects in an animal model of depression, underscoring that plasticity-related mechanisms cut across neurology and psychiatry alike.

Human evidence, though thinner, is provocative. A study of healthy older adults found that resveratrol supplementation improved memory performance and altered hippocampal functional connectivity alongside changes in glucose metabolism, hinting that the compound’s metabolic effects may underpin some of its cognitive benefits. Yet the review is candid about the obstacles. Resveratrol’s bioavailability is notoriously poor, with rapid metabolism limiting the concentrations that actually reach the brain. Dose is a critical variable: infinitesimal quantities appear beneficial for cell growth, while elevated doses can be detrimental to cell viability, a hormetic profile that complicates any simple recommendation. The literature also documents potential adverse effects, meaning that higher is emphatically not better.

The authors conclude that resveratrol’s ability to modulate signaling pathways governing cell survival, apoptosis, and synaptic plasticity gives it genuine potential to mitigate cognitive decline, particularly through enhancement of hippocampal plasticity and adult neurogenesis. But the path forward, they suggest, lies in resolving the dose-response paradox, improving delivery to the central nervous system, and validating the molecular mechanisms in rigorous clinical studies. For now, the compound remains a compelling research tool and a candidate therapeutic scaffold rather than a proven memory pill, a reminder that in neuroscience, as in the synapses themselves, the dose and the context determine everything.

Subject of Research: Resveratrol's modulation of synaptic plasticity and its therapeutic potential for cognitive decline

Article Title: Resveratrol as a modulator of synaptic plasticity: molecular mechanisms and future therapeutic perspectives

Article References: Resveratrol as a modulator of synaptic plasticity: molecular mechanisms and future therapeutic perspectives. (n.d.). https://doi.org/10.1007/s11033-026-12836-1

Image Credits: AI Generated

DOI: 10.1007/s11033-026-12836-1

Keywords: resveratrol, synaptic plasticity, hippocampus, oxidative stress, reactive oxygen species, long-term potentiation, SIRT1, BDNF, adult hippocampal neurogenesis, neuroprotection, CREB, NMDA receptor